Where to buy Pembrolizumab

Pembrolizumab is a monoclonal antibody against programmed cell death protein 1 (PD-1) approved by the U.S. Food and Drug Administration (FDA). It is sold in the United States and initially received accelerated approval from the FDA for refractory advanced melanoma in September 2014. It has subsequently been approved for the treatment of many other oncological diseases, with many currently in clinical development.

Pembrolizumab is a humanized monoclonal IgG4 antibody directed against human cell surfacePD-1 on lymphocytes. The PD-1 receptor provides an important "immune checkpoint" that helps prevent the immune system from attacking itself. Certain tumor types have high expression of PD-L1 (programmed death receptor ligand-1), other tumor types use adaptive immune resistance, in which they employ PD-L1-induced protection from immune-mediated damage against infection and adapt it to anti-tumor responses.

PembrolizumabThe original drug is already on the market in China. SpecificationsThe price per box of 100mg/4ml may be around RMB 15,000. This drug is a strictly controlled drug and has not yet been included in medical insurance. It is difficult to purchase it in China. Pembrolizumab The specifications of the European version of the original drug listed overseasThe price of 100mg/4ml per box may be around 25,000 yuan, and the price of the Turkish version of 100mg/4ml per box may be The price is around RMB 10,000 (the price may fluctuate due to the exchange rate). The ingredients of the original drugs at home and abroad are basically the same and the price is expensive. Currently, there are no generic drugs of pembrolizumab available overseas. For more drug information and specific prices, please consult Yade Medical Consultants.